Hope for rare bone and skin condition: new drug trial launches

This study tests whether etanercept, a drug that blocks inflammation, can reduce pain and disease activity in adults with SAPHO syndrome—a rare condition affecting bones, joints, and skin. Participants must have tried standard treatments like NSAIDs without enough relief. The trial compares etanercept to a placebo over 12 weeks to see if it improves symptoms.